Audiologists in Allenhurst, NJ Accepting Medicare
4 Audiologists found. Showing 1 - 4
 American Family Tinnitus Center Llc Audiologist Medicare: Not Enrolled in Medicare Practice Location: 402 Main St, Allenhurst, NJ 07711 Phone: 732-517-1200 Fax: 732-663-0179 |
American Family Hearing Center Audiologist Medicare: Medicare Enrolled Practice Location: 402 Main St, Allenhurst, NJ 07711 Phone: 732-517-1200 Fax: 732-663-0179 |
 Dr. Jennifer Ann Schaal-sampson, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 402 Main St, Allenhurst, NJ 07711 Phone: 732-517-1200 Fax: 732-663-0179 |
Shelley Secoolish Hamilton, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 402 Main St, Allenhurst, NJ 07711 Phone: 732-517-1200 Fax: 732-663-0179 |
News Archive
KHN's ‘What the Health?': Delta blues
The U.S. is experiencing another surge of covid-19, particularly in Southern states where vaccination rates are generally lower than in other regions. But partisan fights rage on over what role government should play in trying to tamp down the highly contagious delta variant.
arGEN-X to develop its SIMPLE Antibody engine with completed EUR 12.5M Series A equity financing
arGEN-X BV, a biopharmaceutical company focused on the discovery and development of human antibodies using its proprietary SIMPLE Antibody(TM) platform, today announced the successful second closing of its Series A equity financing round. The Company raised an additional EUR 3.0 million (~USD 4.5 million) from two leading life science investors, Credit Agricole Private Equity and VIB (the prestigious Flemish research institute).
Efforts needed to address financial stability of entitlement programs
The "demands imposed by the retirement of millions of baby boomers will consume the federal budget and blight the prospects of the next generations" without efforts to address problems with the long-term financial stability of Medicare and other entitlement programs, columnist David Broder writes in the Washington Post.
Catalyst Pharmaceutical Partners, NIDA partner to conduct CPP-109 Phase II(b) clinical trial for cocaine addiction
Catalyst Pharmaceutical Partners, Inc. announced today that it has signed a non-binding Letter of Intent with the National Institute on Drug Abuse (NIDA) to conduct a U.S. Phase II(b) clinical trial evaluating CPP-109, Catalyst's formulation of vigabatrin, for the treatment of cocaine addiction. It is anticipated that NIDA, under their agreement with Veteran's Administration Cooperative Studies Program, will provide substantial resources for the trial and that Catalyst will contribute approximately $2.5 million in resources as part of the estimated $10 million trial cost.
Activeion Cleaning Solutions announces new European subsidiary, Activeion GmbH
Activeion Cleaning Solutions LLC, Rogers, MN USA is proud to announce its new European subsidiary, Activeion (Europe) GmbH. Activeion (Europe) GmbH will distribute and market the ionator EXP™ throughout Europe, the Middle East and Africa. Activeion's ionator EXP™ is a handheld, on-demand, completely chemical-free cleaning tool that activates and converts tap water into ionised water, a powerful dirt-removing and bacteria-killing product.
› Verified 4 days ago